首页 | 本学科首页   官方微博 | 高级检索  
     


Bevacizumab for Metastatic Colorectal Cancer: A Global Cost‐Effectiveness Analysis
Authors:Daniel A. Goldstein  Qiushi Chen  Turgay Ayer  Kelvin K. W. Chan  Kiran Virik  Ariel Hammerman  Baruch Brenner  Christopher R. Flowers  Peter S. Hall
Affiliation:1. Davidoff Center, Rabin Medical Center, Petach, Tikvah, Israel;2. Winship Cancer Institute, Emory University, Atlanta, Georgia, USA;3. H. Milton Stewart School of Industrial & Systems Engineering, Georgia Institute of Technology, Atlanta, Georgia, USA;4. Sunnybrook Health Sciences Centre, Toronto, Canada;5. Canadian Centre for Applied Research in Cancer Control, Vancouver, British Columbia, Canada;6. Department of Medicine, University of Tasmania, Tasmania, Australia;7. Clalit Health Services Headquarters, Tel Aviv, Israel;8. Sackler Faculty of Medicine, Tel‐Aviv University, Ramat Aviv, Tel‐Aviv, Israel;9. Edinburgh Cancer Research Centre, University of Edinburgh, United Kingdom
Abstract:
Keywords:Cost  Cost‐effectiveness  Colorectal cancer  Economics  Value  Chemotherapy
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号